Diagnose HDV infection in patient with documented acute or chronic HBV and at risk for HDV infection. Consider ordering HBV IgM core antibody testing to determine whether HDV infection is a coinfection or a superinfection with HBV.
Qualitative Enzyme Immunoassay
Mon, Wed, Fri
New York DOH Approval Status
Serum separator tube.
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL) Also acceptable: Citrate, EDTA, or heparin plasma.
Room temperature specimens. Specimens containing particulate material or obvious microbial contamination. Hemolyzed or lipemic specimens.
After separation from cells: Ambient: Unacceptable; Refrigerated: 5 days; Frozen: Indefinitely (avoid repeated freeze/thaw cycles)
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Order this assay only when patient has an acute or chronic hepatitis B infection. This test detects total antibodies (IgG and IgM) to the hepatitis Delta agent.
|Component Test Code*||Component Chart Name||LOINC|
|0020799||Hepatitis Delta Antibody||40727-0|
- HDV Ab